Publicacións nas que colabora con LUIS SABATER ORTI (20)

2024

  1. ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients

    Translational Research, Vol. 271, pp. 105-115

2023

  1. "Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction"

    Journal of experimental & clinical cancer research : CR, Vol. 42, Núm. 1, pp. 8

2021

  1. Circulating tumor dna detection by digital-droplet pcr in pancreatic ductal adenocarcinoma: A systematic review

    Cancers, Vol. 13, Núm. 5, pp. 1-14

2020

  1. Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: Oncological outcomes at a single academic centre

    ESMO Open, Vol. 5, Núm. 6

2019

  1. Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy?: A Multicenter, Randomized, Controlled Trial

    Annals of Surgery, Vol. 270, Núm. 5, pp. 738-746

2018

  1. Borderline resectable pancreatic cancer. Challenges and controversies

    Cancer Treatment Reviews, Vol. 68, pp. 124-135

  2. Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine–erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)

    Cancer Chemotherapy and Pharmacology, Vol. 82, Núm. 6, pp. 935-943

  3. Pathology reporting of resected pancreatic/periampullary cancer specimen

    Surgery for Pancreatic and Periampullary Cancer: Principles and Practice (Springer Singapore), pp. 247-280

2017

  1. mRNA expression profiles obtained from microdissected pancreatic cancer cells can predict patient survival

    Oncotarget, Vol. 8, Núm. 62, pp. 104796-104805

2016

  1. Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma

    Medicina Clinica, Vol. 147, Núm. 10, pp. 465.e1-465.e8

2014

  1. Implicaciones pronósticas del estudio estandarizado de los márgenes de resección en el cáncer de páncreas

    Cirugia Espanola, Vol. 92, Núm. 8, pp. 532-538

  2. Outcome quality standards in pancreatic oncologic surgery

    Annals of Surgical Oncology, Vol. 21, Núm. 4, pp. 1138-1146

2013

  1. Hepatocolangiocarcinoma combinado. Claves para su diagnóstico anatomopatológico

    Revista Espanola de Patologia, Vol. 46, Núm. 2, pp. 73-78

  2. High microvessel density in pancreatic ductal adenocarcinoma is associated with high grade

    Virchows Archiv, Vol. 462, Núm. 5, pp. 541-546

2011

  1. Foregut cystic malformations in the pancreas. Are definitions clearly established?

    Journal of the Pancreas, Vol. 12, Núm. 4, pp. 420-424

2010

  1. Protocolo de tallado, estudio e informe anatomopatológico de las piezas de duodenopancreatectomía cefálica por carcinoma de páncreas

    Revista Espanola de Patologia

2007

  1. Erratum: Co-administration of pentoxifylline and thiopental causes death by acute pulmonary oedema in rats (British Journal of Pharmacology (2006) 149, (450-455) DOI: 10.1038/sj.bjp.0706871)

    British Journal of Pharmacology

2006

  1. Co-administration of pentoxifylline and thiopental causes death by acute pulmonary oedema in rats

    British Journal of Pharmacology, Vol. 149, Núm. 4, pp. 450-455

2005

  1. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: Relevance for diagnosis of autoimmune pancreatitis

    Gut, Vol. 54, Núm. 5, pp. 703-709

2004

  1. Effect of simultaneous inhibition of TNF-α production and xanthine oxidase in experimental acute pancreatitis: The role of mitogen activated protein kinases

    Annals of Surgery, Vol. 240, Núm. 1, pp. 108-116